Amundi Technology Partners with Murex to Deliver Superior OTC Derivatives Capabilities to Investment Managers

PARIS, April 10, 2025 — Amundi Technology and Murex have entered into a partnership to provide investment managers with a combined offering that brings together the multi-asset class capabilities of ALTO and Murex’s industry leading OTC front-to-back solution.

This collaboration will enable Amundi Technology clients to leverage Murex’s robust, proven functionalities through ALTO Investment, Amundi Technology’s platform dedicated to asset managers, insurers, pension funds and family offices.

ALTO enhances asset management with its advanced portfolio management features and integrated market data, allowing asset managers to make informed decisions while reducing operational risks. By adopting this new combined offering, clients gain access to a comprehensive and reliable solution that aligns with the evolving demands of today’s market.

Furthermore, clients benefit from Murex’s extensive instrument coverage and robust OTC functionality through ALTO’s open architecture. This includes seamless integration with the Murex MX.3 platform, providing advanced tools for managing OTC derivatives, such as payoff modeling, lifecycle event management, and insightful risk analytics—all designed to enhance operational efficiency and enable more accurate assessments.

Amundi leverages MX.3 to manage its OTC derivatives portfolios front-to-back and has worked with Murex since 2007.

“We are delighted to be building on our long-standing relationship with Amundi Group. Our companies share a commitment to excellence in technology, research and development,” said Maroun Eddé, Murex president. “Through this new agreement, Amundi Technology clients will have access to Murex’s extensive global OTC derivatives coverage, which is used daily by Amundi Group's asset management companies around the world. The integration of Murex's market-leading OTC derivatives capabilities will support ALTO client expansion into the most complex portfolio strategies.”

“Investment managers are pursuing increasingly complex strategies and demanding more advanced OTC functionality,” said Benjamin Lucas, CEO of Amundi Technology. “ALTO clients can now have the OTC processing power they need through our partnership with Murex, all in a single solution provided by Amundi Technology. This is another example of how an open architecture can help investment managers to simplify their operating models by connecting market-leading solutions in a single platform.”